Search DLB
Dolby Laboratories, Inc.
NYSE · CIK 1308547
Last close58.89
Daily change-0.17 (-0.29%)
10 Years gain+26.61%
Dividends TTM1.44 (+9.09%)
Dividend yield2.44%
Fundamental Analysis
DLB · STANDARD
SIC 6794 · Patent Owners & Lessors · Fiscal year end 0927
Fundamental
49.0Momentum
23.5Acceleration
24.6Confidence
100.0Annual Revenue18
Quarterly Revenue78
Annual CFO18
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth1.1 / 25
Quality18.9 / 25
Capital Efficiency9.1 / 20
Balance Sheet14.8 / 15
Shareholder Economics5.1 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 3.0296%.
Warnings
FCF deterioration · MEDIUMFree cash flow declined 23.5157%.
Operating margin compression · MEDIUMOperating margin compressed by 5.2991 percentage points.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
ROIC declining · MEDIUMROIC declined by 4.7338 percentage points.
Key Metrics
Revenue Growth TTM-1.23%OK
Revenue CAGR 3Y2.47%OK
Gross Margin87.36%OK
Operating Margin18.86%OK
FCF Margin25.49%OK
FCF Growth-23.52%OK
ROIC10.31%OK
Incremental Operating Margin 3Y54.39%OK
Net Debt / CFO-1.75xOK
Diluted Share Growth 1Y-3.03%OK
SBC / Revenue9.51%OK
SBC / FCF37.31%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 26, 2025 | $1.35B | $1.19B | $264.96M | $472.20M | $435.85M | 88.13% | 19.64% | 32.31% | 11.44% | 97.48M |
| 2025 FY Sep 27, 2024 | $1.27B | $1.13B | $258.33M | $327.25M | $297.25M | 88.97% | 20.28% | 23.34% | 12.61% | 97.33M |
| 2025 FY Sep 29, 2023 | $1.30B | $1.15B | $215.75M | $367.08M | $336.74M | 88.26% | 16.6% | 25.91% | 11.97% | 97.73M |
| 2024 FY Sep 30, 2022 | $1.25B | $1.11B | $206.61M | $318.58M | $270.65M | 88.73% | 16.48% | 21.59% | 12.74% | 101.98M |
| 2023 FY Sep 24, 2021 | $1.28B | $1.15B | $344.39M | $447.75M | $393.30M | 89.85% | 26.88% | 30.7% | 23.32% | 104.62M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.36B | sum latest 4 fiscal quarters Revenue | OK | 0001308547-26-000013, 0001308547-26-000005 |
| Revenue Growth TTM | -1.23% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001308547-26-000013, 0001308547-26-000005 |
| Revenue CAGR 3Y | 2.47% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001308547-25-000007 |
| Revenue CAGR 5Y | 3.04% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001308547-25-000007 |
| Gross Profit CAGR 3Y | 2.24% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001308547-25-000007 |
| Operating Income Growth | -22.9% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001308547-26-000013, 0001308547-26-000005 |
| FCF Growth | -23.52% | FCF_current / FCF_prior_year - 1 | OK | 0001308547-26-000013, 0001308547-26-000010 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 87.36% | Gross Profit / Revenue | OK | 0001308547-26-000013, 0001308547-26-000005 |
| Operating Margin | 18.86% | Operating Income / Revenue | OK | 0001308547-26-000013, 0001308547-26-000005 |
| FCF Margin | 25.49% | (CFO - CapEx) / Revenue | OK | 0001308547-26-000013, 0001308547-26-000010 |
| CFO / Net Income | 1.72x | CFO / Net Income | OK | 0001308547-26-000013, 0001308547-26-000010 |
| FCF / Net Income | 1.56x | FCF / Net Income | OK | 0001308547-26-000013, 0001308547-26-000010 |
| ROIC | 10.31% | NOPAT / Average Invested Capital | OK | 0001308547-26-000013, 0001308547-26-000005 |
| Net Debt / CFO | -1.75x | Net Debt / CFO | OK | 0001308547-26-000013, 0001308547-26-000010 |